Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Revolution Medicine’s Elironrasib Receives FDA Breakthrough Therapy Status for KRAS G12C-Mutated Lung Cancer
Revolution Medicines has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for its investigational drug, elironrasib. ...
FDA Grants Breakthrough Therapy Status to Avidity Biosciences' Del-zota for DMD44
Avidity Biosciences has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for its investigational therapy, delpacibart zotadirsen (del-zota). ...
Ensysce Biosciences Receives Positive FDA Feedback on PF614-MPAR for Opioid Safety
Ensysce Biosciences has received encouraging feedback and regulatory guidance from the U.S. Food and Drug Administration (FDA) regarding its novel pain relief product, PF614-MPAR....
FDA Grants Breakthrough Status to Praxis’s Relutrigine Post-EMBOLD Trial
Praxis Precision Medicines has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for relutrigine (PRAX-562)....
US FDA Approves EKTERLY® as First Oral On-Demand Treatment for HAE
KalVista Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a new oral plasma kallikrein inhibitor, for the treatment of acute attacks of hereditary angioedema (HAE)...
Hikma Gains FDA Approval for Novel TYZAVAN™, a Ready-to-Use Vancomycin Injection
Hikma Pharmaceuticals PLC has received approval from the U.S. Food and Drug Administration (FDA) for TYZAVAN™ (Vancomycin Injection, USP), a novel, ready-to-infuse form of the widely used antibiotic vancomycin. ...
Kelun-Biotech's Sac-TMT and Tagitanlimab Receives Breakthrough Therapy Designation
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced that its TROP2-targeting antibody-drug conjugate, sacituzumab tirumotecan, combined with the PD-L1 monoclonal antibody tagitanlimab, has been granted Breakthrough...
Innovent Biologics Receives Breakthrough Therapy Designation for Novel Lung Cancer Treatment
Innovent Biologics has been granted a second Breakthrough Therapy Designation by the Centre for Drug Evaluation (CDE), part of China’s National Medical Products Administration. ...
Cellectar Receives FDA Breakthrough Therapy Designation for Iopofosine I-131
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Cellectar Biosciences for its lead candidate, iopofosine I-131...
PharmAla Biotech Introduces Novel Phenesafe AI Platform to Discover New Phenethylamine Compounds
PharmAla Biotech Holdings, a biotechnology firm specialising in the research, development, and manufacture of LaNeo™ MDMA and new MDMA derivatives (MDXX class molecules), has officially launched its Phenesafe AI platform. ...
